|
|
||||||||||
|
J Am Coll Cardiol, 2005; 45:828-831, doi:10.1016/j.jacc.2004.11.054 © 2005 by the American College of Cardiology Foundation |





* Deutsches Herzzentrum, Technischen Universität, Munich, Germany
1. Medizinische Klinik rechts der Isar, Technischen Universität, Munich, Germany
Nuklearmedizinische Klinik rechts der Isar, Technischen Universität, Munich, Germany
Manuscript received October 1, 2004; revised manuscript received November 16, 2004, accepted November 22, 2004.
* Reprint requests and correspondence: Dr. Julinda Mehilli, Deutsches Herzzentrum, Lazarettstr. 36, 80636 München, Germany (Email: mehilli{at}dhm.mhn.de).
| Abstract |
|---|
|
|
|---|
BACKGROUND: Despite having a more adverse cardiovascular risk profile, women with AMI have similar or even better outcomes after primary PCI compared with men. The reasons for these findings are unclear.
METHODS: In this study we included 202 women and 561 men with AMI who underwent primary PCI in the setting of three randomized trials. The primary end point of the study was myocardial salvage index (proportion of initial perfusion defect salvaged by reperfusion therapy), obtained by paired scintigraphic studies performed 7 to 10 days apart.
RESULTS: The amount of myocardium at risk or initial perfusion defect (median [25th, 75th percentiles]) did not differ significantly between women and men (22.0% [12.0, 40.0] vs. 24.0% [14.0, 39.0] of the left ventricle [LV], p = 0.26). Final infarct size, measured in the follow-up scintigraphy, was significantly smaller in women than in men (6.0% [0.71, 18.7] vs. 10.0% [3.9, 21.8] of the LV, p = 0.001). Myocardial salvage index was 0.64 (0.35, 0.95) in women versus 0.50 (0.26, 0.77) in men (p < 0.001). After adjustment for baseline characteristics, female gender was an independent predictor of greater myocardial salvage after PCI (p = 0.002).
CONCLUSIONS: The efficacy of primary PCI in patients with AMI appears to be gender-dependent. Myocardial salvage achieved by primary PCI is greater in women than in men.
| ||||||||||
| Methods |
|---|
|
|
|---|
Detailed information about patient enrollment and study designs has been previously published (35). Shortly, all patients received 500 mg of aspirin and a bolus of 60 U/kg of heparin intravenously. In addition, they received an intravenous injection of 27 mCi of 99mtechnetium (Tc)-sestamibi required for the baseline scintigraphic study. In patients without contraindications, abciximab was used as adjunct therapy. Post-interventional oral antiplatelet therapy consisted of ticlopidine, given at a dose of 250 mg twice daily, or clopidogrel, given at a dose 75 mg daily, for four weeks, and aspirin given at a dose of 100 mg twice a day indefinitely. Qualitative and quantitative assessment of digital angiograms was performed off-line using the automated edge detection system CMS (Medis Medical Imaging Systems, Nuenen, the Netherlands) in the Angiographic Core Laboratory. Classification of anterograde coronary flow in the infarct-related artery was done according to Thrombolysis In Myocardial Infarction (TIMI) classification (6). Collateral circulation was quantified according to Rentrop et al. (7). Post-discharge clinical follow-up consisted of telephone interviews at one month and a hospital visit at six months after the initial procedure.
99mTc-sestamibi scintigraphy. The first scintigraphy was performed within six to eight hours after injection of 27 mCi (1,000 MBq) of 99mTc-sestamibi. A follow-up scintigraphy was scheduled 7 to 10 days after intervention. Paired scintigraphic examinations were used to calculate three parameters: initial perfusion defect and final infarct size, both expressed as a percentage of the left ventricle (LV), as well as myocardial salvage, calculated as initial perfusion defect minus final infarct size divided by initial perfusion defect. The measurement of scintigraphic images was performed off-line in the scintigraphic core laboratory by operators unaware of patients' treatment and characteristics.
Of the 763 patients receiving primary PCI in the STOPAMI trials, 634 (83.0%) had technically satisfactory paired 99mTc-sestamibi scintigraphic studies needed for determination of salvage index. No gender-dependent difference in the rate of completed paired scintigraphic studies was observed (161 women, 80.0% vs. 473 men, 84.3%, p = 0.14). The primary end point of the study was the salvage index.
Statistical analysis. The data are presented as median (25th, 75th percentiles) or as counts or proportions. The differences between women and men were assessed with two-sided chi-square test for categorical data or nonparametric Wilcoxon rank sum test for continuous data. Differences in clinical outcome data between women and men were assessed by the use of Mantel-Haenszel analysis with stratification by STOPAMI trial. Multiple linear regression analysis was used to assess the independent impact of gender on myocardial salvage while adjusting for other variables. The following parameters were entered into the model: age, diabetes, arterial hypertension, cholesterol level, smoking, previous myocardial infarction, previous coronary angioplasty, previous coronary bypass graft surgery, Killip class, anterior infarction, time-to-admission interval, initial coronary TIMI flow grade, and pre-infarct angina. A two-tailed p < 0.05 was considered to indicate statistical significance.
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
In the present study, more than 90% of the patients received aggressive antiplatelet therapy with abciximab as an adjunct to PCI. Platelets of women have been demonstrated to show a greater sensitivity to aggregating stimuli (10,11). Thus, women may benefit to a greater degree from effective antiplatelet inhibition by abciximab. Women presenting with AMI in our study reported pre-infarction angina more frequently than men. Pre-infarct angina may have protective effects leading to limitation of the infarct size, a greater myocardial viability upon reperfusion, and an improvement in the long-term survival and left ventricular function (12,13). Ischemic pre-conditioning and enhancement of spontaneous thrombolysis due to adenosine-related platelet aggregation inhibition during angina, leading to an increase in the hypoxic tolerance of the myocardial tissue, have been suggested as underlying explanative mechanisms. Experimental studies have provided evidence that the hypoxic tolerance and its underlying mechanisms are gender-specific (14,15). Female cells present a higher basal expression of the survival-associated protein Bcl-2, showing a higher inherited hypoxic tolerance than male cells. Moreover, upon pre-conditioning, female cellsbecause of a significant lower activation of signaling pathways that control cell apoptosisdevelop a higher tolerance to induced hypoxia than do male cells (16). Another factor possibly playing a role with respect to the increase in hypoxic tolerance seems to be the activation of estrogen receptor in cardiac cells upon pre-conditioning. Because of more functional and a higher density of estrogen receptors, even low blood levels of estrogen may confer resistance to female, but not male, cardiomyocytes against intracellular Ca2+ loading induced by hypoxia-reoxygenation (15).
These gender-related differences in the hypoxia tolerance may result in a better local myocardial response to ischemic injury in women and may explain the greater myocardial salvage in women than in men.
In conclusion, women with acute myocardial infarction treated with mechanical reperfusion and adjunct platelet glycoprotein IIb/IIIa receptor inhibitors show a higher degree of myocardial salvage than men. This may improve the chances of survival of women, despite their more adverse cardiovascular profile.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Singh, C. S. Rihal, B. J. Gersh, V. L. Roger, M. R. Bell, R. J. Lennon, A. Lerman, and D. R. Holmes Jr Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2313 - 2320. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bell, E. R. Porrello, C. E. Huggins, S. B. Harrap, and L. M. D. Delbridge The intrinsic resistance of female hearts to an ischemic insult is abrogated in primary cardiac hypertrophy Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1514 - H1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Brown and R. L. Moore Perspectives in innate and acquired cardioprotection: cardioprotection acquired through exercise J Appl Physiol, November 1, 2007; 103(5): 1894 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Radovanovic, P. Erne, P. Urban, O. Bertel, H. Rickli, J.-M. Gaspoz, and on behalf of the AMIS Plus Investigators Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20 290 patients from the AMIS Plus Registry Heart, November 1, 2007; 93(11): 1369 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy and C. Steenbergen Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury Cardiovasc Res, August 1, 2007; 75(3): 478 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Chicco, M. S. Johnson, C. J. Armstrong, J. M. Lynch, R. T. Gardner, G. S. Fasen, C. P. Gillenwater, and R. L. Moore Sex-specific and exercise-acquired cardioprotection is abolished by sarcolemmal KATP channel blockade in the rat heart Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2432 - H2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Johnson, R. L. Moore, and D. A. Brown Sex differences in myocardial infarct size are abolished by sarcolemmal KATP channel blockade in rat Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2644 - H2647. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |